Carsten Boess
Director · 2 filings · Latest: Feb 27, 2026
Atrium Therapeutics, Inc.
Avidity Biosciences, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
— | BOESS CARSTEN | — | Feb 4, 2025 | Proposed Sale | $1.36 | 25,000 | $34.0K | — |